தொழில்நுட்பம் நுழைவு கட்டமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தொழில்நுட்பம் நுழைவு கட்டமைப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தொழில்நுட்பம் நுழைவு கட்டமைப்பு Today - Breaking & Trending Today

Harvard University licenses its nasal swab collection technology to Rhinostics


 E-Mail
IMAGE: A research team at the Wyss Institute and Harvard Medical School has developed a nasal swab collection technology enabling high-throughput automated sample processing for molecular diagnosis of respiratory diseases including.
view more 
Credit: Wyss Institute at Harvard University
(Boston) The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics. The company will further develop and commercialize automated and multiplexed solutions for processing nasal samples from people suspected to have COVID-19 or other respiratory infectious diseases. The license was coordinated by Harvard s Office of Technology Development (OTD) in accordance with the University s commitment to the COVID-19 Technology Access Fram ....

Boston University , United States , University Of Massachusetts Medical School , Massachusetts Institute Of Technology , Harvard University , Dana Farber Cancer Institute , Tufts University , United Kingdom , Spaulding Rehabilitation Hospital , Donald Ingber , Michael Springer , Benjamin Boettner , Scheri Walker , Richard Novak , Beth Israel Deaconess Medical Center , Wyss Institute , Wyss Institute Founding , Harvard Wyss Institute , Harvard Office Of Technology Development , University Of Zurich , Institute Founding , Vascular Biology Program At Boston Children Hospital , Harvard Medical School , Arts Sciences , Technology Access Framework , Harvard University Office Of Technology Development ,

INTELLECTUAL PROPERTY PLEDGES FOR COVID-19: A SCORECARD


    Duration of WHO-declared COVID-19 pandemic
(a)  Wellcome Trust Publishers Pledge
The first pandemic-related IP pledge addressed copyrights. On January 31, 2020, the Wellcome Trust, a large UK-based medical charity, led a group of approximately thirty scientific and medical publishers in committing to make all peer-reviewed research publications relating to COVID-19 available without charge on an open access basis. The signatories included Elsevier, Cell Press, Karger, the JAMA Network, the New England Journal of Medicine, Oxford University Press, Springer Nature, Taylor & Francis, Wiley, and Wolters Kluwer. The initiative echoed earlier Wellcome-led pledges of similar scope made with respect to research concerning the Zika and Ebola outbreaks. ....

United Kingdom , Stanford University , United States , World Health Organization , Al Qahirah , Taylor Francis , Jorge Contreras , Jennifer Doudna , University Of California , Wellcome Trust Publishers Pledge , Us National Institutes Of Health , Harvard University , Innovative Genomics Institute , Technology Pledge , Moderna Inc , Oxford University , Public Health Emergency Of International Concern Or , Wolters Kluwer , Medtronic Inc , Kyoto University , Massachusetts Institute Of Technology , Technology Access Program , Ventilator Challenge Consortium , Technology Access Framework , Smiths Group , University Of California Berkeley ,

New diagnostic platform can rapidly measure COVID-19-related biomarkers


New diagnostic platform can rapidly measure COVID-19-related biomarkers
The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute s eRapid technology with the company s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.
The research collaboration further cements both parties commitment to bringing the Wyss multiplexed electrochemical detection system forward as a diagnostic tool during the pandemic and follows a licensing agreement coordinated by Harvard s Office of Technology Development (OTD) in November 2020 that granted The iQ Group Global non-exclusive, term-limited access to the eRapid technology in accordance with t ....

United States , George Syrmalis , Pawan Jolly , Paul Dastoor , Donald Ingber , Emily Henderson , School Of Mathematical , Technology Access Framework , Wyss Institute , Wyss Institute Bioinspired Therapeutics , Harvard Office Of Technology Development , Harvard Johna Paulson School Of Engineering , University Of Newcastle , Iq Group Global , Biologically Inspired Engineering , Harvard University , Technology Development , Wyss Founding Director Donald Ingber , Bioinspired Therapeutics , Judah Folkman Professor , Vascular Biology , Harvard Medical School , Boston Children , Harvard John , Wyss Senior Staff Scientist Pawan Jolly , Organic Thin Film Transistor ,

Harvard's Wyss Institute collaborates with GBS Inc. on eRapid-based COVID-19 diagnostic


 E-Mail
IMAGE: The Wyss Institute collaborates with GBS Inc., a subsidiary of The iQ Group Global, to combine its electrochemical eRapid sensing technology with the GBS s transistor technology in developing a multiplexed.
view more 
Credit: Wyss Institute at Harvard University
(BOSTON) The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute s eRapid technology with the company s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications. ....

Boston University , United States , University Of Massachusetts Medical School , Massachusetts Institute Of Technology , Harvard University , Dana Farber Cancer Institute , Tufts University , Spaulding Rehabilitation Hospital , George Syrmalis , Pawan Jolly , Paul Dastoor , James Gorman , Donald Ingber , Benjamin Boettner , Gemma Garkut , Beth Israel Deaconess Medical Center , Wyss Institute , Harvard Office Of Technology Development , Harvard Johna Paulson School Of Engineering , University Of Zurich , Iq Group Global , School Of Mathematical , Arts Sciences , Technology Access Framework , Harvard University Office Of Technology Development , Wyss Institute Bioinspired Therapeutics ,